Randomised open-label phase II study of induction standard of care fulvestrant and CDK4/6 inhibition with addition of ipatasertib in metastatic ER+/HER2- breast cancer patients wit... von Okines, Alicia Frances Clare, Braybrooke, Jeremy, MacPherson, Iain R., Sutherland, Dr. Stephanie, Howell, Sacha Jon, Wheatley, Duncan, Waters, Simon, Roylance, Rebecca, Baird, Richard D., Oikonomidou, Olga, Palmieri, Carlo, Harries, Mark, Harper-Wynne, Catherine, Sheri, Amna, Khan, Sarah, Bunce, Catey, Mohammed, Kabir, Lee, Dymphna, Turner, Nicholas C.

Volltext